WebbLONDON and JERSEY CITY, N.J., March 30, 2024 (GLOBE NEWSWIRE) -- GSK plc (LSE/NYSE: GSK) and SCYNEXIS, Inc. (NASDAQ: SCYX), today announced they have entered into an exclusive licence agreement for Brexafemme (ibrexafungerp tablets), a US FDA approved, first-in-class antifungal for the treatment of vulvovaginal candidiasis … Webb30 mars 2024 · Today’s news brings with it heavy trading for SCYX stock as investors buy shares. As of this writing, more than 22 million shares have changed hands. That’s a …
SCYNEXIS to Present Ibrexafungerp Data at the 33rd Annual …
WebbFör 1 dag sedan · JERSEY CITY, N.J., April 13, 2024 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. SCYX, a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation of interim data across a diverse array of infection types from its ongoing Phase 3 FURI and CARES … WebbSCYNEXIS, Inc. (SCYX) Stock Price, News, Quote & History - Yahoo Finance My Portfolio U.S. Markets closed S&P 500 Dow 30 33,485.29 (+0.01%) Nasdaq 12,087.96 … tessera lake travis pid
SCYNEXIS (@scynexis) / Twitter
WebbSCYNEXIS News: This is the News-site for the company SCYNEXIS on Markets Insider. ... Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday. … Webb7 apr. 2024 · SCYNEXIS stock price predictions for 2025 using ... the Average Price over the previous 50/200 days. For SCYNEXIS stocks, the 50-day moving average is the … WebbFör 1 dag sedan · SCYNEXIS, Inc. SCYX + Free Alerts is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are... tessera kiabi